The Link Between Mitochondrial Disease and Severe Autism
Emerging evidence suggests a significant link between mitochondrial dysfunction and autism spectrum disorders (ASD), particularly in cases with autistic behaviors and speech regression following febrile illness or immunization with subsequent encephalopathy. 1, 2
Clinical Indicators of Mitochondrial Disease in ASD
- Constitutional symptoms, hypotonia, repeated regressions after age 3, and multiple organ dysfunctions are key clinical indicators suggesting mitochondrial disease in patients with ASD 1, 2
- High lactate levels, reported in approximately 20% of children with ASD, may indicate involvement of mitochondria in energy metabolism and brain development 3
- Clinical presentations that should raise suspicion include:
- Neurodegeneration or developmental regression atypical for autism 1
- Worsening neurological symptoms, lethargy, and poor physical endurance 1
- Seizures, which may be associated with both mitochondrial dysfunction and ASD 1
- Physiologic abnormalities such as acidosis 1
- Multisystem involvement, particularly cardiac, hepatic, or renal manifestations 1
Prevalence and Significance
- Population-based studies have confirmed that approximately 4% of children with ASD can be diagnosed with definite mitochondrial disease 3
- However, biomarker research suggests that abnormalities of mitochondrial function could affect a much higher percentage of children with ASD, potentially up to 80% 3
- Mitochondrial disorders in ASD are considered "low incidence yet high impact" according to the American College of Medical Genetics and the Society for Inherited Metabolic Disorders 1
Types of Mitochondrial Dysfunction in ASD
- Recent research has identified a novel type of mitochondrial dysfunction in which electron transport chain activity is significantly increased, potentially associated with environmental exposures and neurodevelopmental regression 3
- Mitochondrial disturbances can include:
Diagnostic Approach
- A careful medical history for true developmental regression, worsening neurological symptoms, lethargy, poor physical endurance, or seizures is critical 1
- Metabolic screening should be considered in patients with ASD who show signs of metabolic disorders, including:
- For suspected mitochondrial dysfunction, appropriate mitochondrial testing should be considered 6
- Neuroimaging with magnetic resonance imaging (MRI) may be helpful in patients with ASD and neurological symptoms 1, 6
Treatment Implications
- Several treatments targeting mitochondria have shown evidence for potential benefit in children with ASD, including:
- For patients with folate metabolism issues (which can affect mitochondrial function), leucovorin therapy may be considered after appropriate testing 6
- When using medications like aripiprazole in ASD patients with mitochondrial dysfunction, special monitoring is required due to the risk of exacerbating metabolic issues 2
Genetic Considerations
- Multiple genetic abnormalities are associated with mitochondrial dysfunction in ASD, including:
- Genetic testing should be considered, particularly for folate metabolism pathway variants which may guide treatment 6
Cautions and Controversies
- Finding biochemical or structural mitochondrial abnormalities in an autistic child does not necessarily imply a primary mitochondrial disorder but can also be secondary to technical inaccuracies or another genetic disorder 7
- Clinicians should be careful in diagnosing a mitochondrial disorder in an autistic child because it has important implications for accurate genetic counseling, prognosis, and therapy 7
- The exact etiology of mitochondrial dysfunction and how to define it in ASD remains unclear, though preliminary evidence suggests mitochondria may be a fruitful target for treatment and prevention 5